Global Vitamins, Minerals, and Supplements CDMO Market Size Likely to Grow at a CAGR of 9.95% By 2034

Market Size and Growth

As per the Vitamins Minerals and Supplements CDMO Market size analysis conducted by the CMI team, the vitamins, minerals, and supplements CDMO market is expected to record a CAGR of 9.95% from 2025 to 2034. In 2025, the market size was USD 46.55 Billion. By 2034, the valuation is anticipated to reach USD 105.90 Billion.

Overview

As per the industry experts at CMI, the global vitamins, minerals, and supplements CDMO market will witness a robust CAGR between 2025 and 2034. This could be attributed to growing interest in nutraceuticals amongst Gen Z and millennials resulting in rising demand for digitally native brands and continual product innovation with more complicated modalities. The increase in the aging population is also prompting healthcare personnel to prescribe nutraceuticals for them.

The contract development and manufacturing organizations (CDMOs) are emerging as one of the attractive opportunities regarding the creation of value-based nutritional services. Plus, the CDMOs help in alleviation from the burden of regulatory compliance and help brands in focusing on their core competencies (especially marketing and sales).

Key Trends & Drivers

• Multiple Value-Creation Opportunities to Spell Growth: The interest of the investors in the CDMO space has been increasing since the last few years, which has actually contributed to deals of higher valuations. Several deals have emphasized companies having a diverse list of customers, agreements of exclusivity with customers, in-house R&D, and a track record of stability and growth. The segments that are likely to be outsourced to CDMO include non-pill formats such as liquids and gummies and the ones pertaining to wellbeing product categories such as mood, mind, and sleep.

• Call for Strengthening Outbound Sales Efforts to Catalyze Growth: The CDMOs are creating one-stop-shop solutions across various modalities and service offerings for customers. They are also investing in infrastructure and a business development team for energizing efforts pertaining to outbound sales. Scaling of back-office operations and rationalization of supply chains are also driving the need for deployment of CDMOs.

Report Scope

SWOT Analysis

• Strengths: CDMOs do offer end-to-end services, right from initial development to ultimate packaging and production, thereby easing the burden on the brands. They also make provisions for specialized knowledge in quality control, formulation, and regulatory compliance. They are also capable of handling various production volumes, thereby aiding clients in upscaling their operations.

• Weaknesses: Market disruptions are likely to result in production delays and demand-supply gaps. Certain conventional processes like sourcing and quoting could prove to be inefficient with improper technology management.

• Opportunities: Consumers are increasingly asking for tailored solutions. With consumers shifting to proactive health management, the demand for vitamins, minerals, and supplements CDMO is increasing. Implementation of AI and the other technologies is capable of improving efficiency in sourcing and quoting.

• Threats: The market is likely to face threats from stringent regulatory standards regarding dietary supplements. The worldwide economic slowdown could also adversely affect consumers’ spending on the supplements.

List of the prominent players in the Vitamins, Minerals, and Supplements CDMO Market:

• Catalent Inc.
• Lonza
• Nutrascience Labs
• Robinson Pharma Inc.
• Health Wright Products Inc.
• INPHARMA S.p.A.
• Aenova Group
• NutraPak USA
• SFI Health
• Others

The Vitamins, Minerals, and Supplements CDMO Market is segmented as follows:

By Type

• Vitamins
• Minerals
• Dietary Supplements

By Dosage Form

• Tablets & Capsules
• Powder
• Softgel

By Company Size

• Small Companies
• Mid-sized Companies
• Large Companies

By Service Type

• Product Formulation and Development
• Manufacturing and Packaging
• Research & Development
• Regulatory Compliance

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America